These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6137754)

  • 1. Extrapancreatic action of sulfonylureas: hypoglycemic effects are not dependent on altered insulin binding or inhibition of transglutaminase.
    Nowak SM; McCaleb ML; Lockwood DH
    Metabolism; 1983 Apr; 32(4):398-402. PubMed ID: 6137754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylurea effects on target tissues for insulin.
    McCaleb ML; Maloff BL; Nowak SM; Lockwood DH
    Diabetes Care; 1984; 7 Suppl 1():42-6. PubMed ID: 6376028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.
    Maloff BL; Lockwood DH
    J Clin Invest; 1981 Jul; 68(1):85-90. PubMed ID: 7019248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of transglutaminase by hypoglycaemic sulphonylureas in pancreatic islets and its possible relevance to insulin release.
    Gomis R; Mathias PC; Lebrun P; Malaisse-Lagae F; Sener A; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):331-49. PubMed ID: 6151221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
    De Vries CP; van der Veen EA
    Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapancreatic effects of sulfonylureas. Potentiation of insulin action through post-binding mechanisms.
    Lockwood DH; Maloff BL; Nowak SM; McCaleb ML
    Am J Med; 1983 Jan; 74(1A):102-8. PubMed ID: 6401922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of sulfonylureas on the secretion, disposal and effect of insulin.
    Almér LO; Johansson E; Melander A; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1982; 22(1):27-32. PubMed ID: 7047169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular loci of sulfonylurea actions.
    Lebovitz HE
    Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic rats.
    Salhanick AI; Konowitz P; Amatruda JM
    Diabetes; 1983 Mar; 32(3):206-12. PubMed ID: 6337899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapancreatic action of the sulphonylurea gliquidone: post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary culture.
    Rinninger F; Kirsch D; Häring HU; Kemmler W
    Diabetologia; 1984 Jun; 26(6):462-5. PubMed ID: 6381193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes.
    Müller G; Geisen K
    Horm Metab Res; 1996 Sep; 28(9):469-87. PubMed ID: 8911985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic sensitivity to insulin: effects of sulfonylurea drugs.
    Del Prato S; Vigili de Kreutzenberg S; Riccio A; Tiengo A
    Am J Med; 1991 Jun; 90(6A):29S-36S. PubMed ID: 1872301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hypoglycemic sulfonylureas on human red blood cell transglutaminase activity.
    Gomis R; Casanovas A; Casamitjana R; Sarto A; Arroyo J; Coves MJ; Rivera F; Vilardell E
    Diabetes Res Clin Pract; 1988 May; 5(1):31-6. PubMed ID: 2900125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.
    Putnam WS; Andersen DK; Jones RS; Lebovitz HE
    J Clin Invest; 1981 Apr; 67(4):1016-23. PubMed ID: 7009650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin binding on MOLT 4 cells: effect of a sulfonylurea.
    Cordera R; Chimini G; Bagnasco M; Gherzi R
    Horm Res; 1984; 20(4):246-51. PubMed ID: 6392057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids.
    Brown GR; Foubister AJ
    J Med Chem; 1984 Jan; 27(1):79-81. PubMed ID: 6361256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glipizide on muscle metabolism in vitro.
    Bloch K; Daturi S; Tommasini R
    Acta Endocrinol Suppl (Copenh); 1980; 239():23-5. PubMed ID: 7001841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.